Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy
Filippo Crea
Abstract
Contains fulltext : 246128.pdf (Publisher’s version ) (Open Access)
Topics & Concepts
MedicineTicagrelorPrasugrelConventional PCICardiologyInternal medicinePercutaneous coronary interventionMyocardial infarctionAntiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and DiagnosticsAcute Myocardial Infarction Research